手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| CHA₂DS₂-VAScスコア× | qSOFAスコア× | |
|---|---|---|
| 分野 | 臨床評価 | 臨床評価 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2010 | 2016 |
| 提唱者≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | Sepsis-3 Taskforce |
| 種類≠ | Atrial fibrillation stroke risk stratification | Rapid sepsis screening |
| 原典≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810. DOI ↗ |
| 別名 | CHA2DS2VASc, Atrial fibrillation stroke risk | Quick SOFA, qSOFA |
| 関連 | 3 | 3 |
| 概要≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing. |
| ScholarGateデータセット ↗ |
|
|